Management of Plaque Psoriasis: A Review and Comparison of IL-23 Inhibitors

Management of Plaque Psoriasis: A Review and Comparison of IL-23 Inhibitors

With the recent advancements of biologic therapies that block IL-23, there is increasing need for analysis of which biologics are most efficacious in treatment of plaque psoriasis. Guselkumab and risankizumab have each individually been compared to adalimumab in head-to-head trials, but no prior cli...

Full description

Bibliographic Details
Main Authors: Nicole L. Bolick, Rima I. Ghamrawi, Steven R. Feldman
Format: Article
Language:English
Published: European Medical Journal 2020-12-01
Series:European Medical Journal Dermatology
Subjects:
adalimumab
adalimumab psoriasis
guselkumab
guselkumab psoriasis
plaque psoriasis
risankizumab
risankizumab psoriasis
tildrakizumab
ustekinumab
Online Access:https://www.emjreviews.com/dermatology/article/management-of-plaque-psoriasis-a-review-and-comparison-of-il-23-inhibitors/

Internet

https://www.emjreviews.com/dermatology/article/management-of-plaque-psoriasis-a-review-and-comparison-of-il-23-inhibitors/

Similar Items